News
Novo Nordisk rises as Hims & Hers backs down on oral GLP-1
Novo Nordisk's battered stock enjoyed a reprieve after Hims & Hers abandoned plans to launch a compounded version of the new Wegovy pill.
News
White House's TrumpRx platform has arrived
The Trump administration's long-promised direct-to-consumer (DTC) sales channel for medicines, TrumpRx, has finally gone live.
Digital
From engagement metrics to meaningful experience: Why pharma...
Pharma digital success still focuses on clicks and downloads, but true performance is whether content actually meets real end-user needs
News
Hims & Hers copies Novo Nordisk's new Wegovy pill
Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.
News
Abbott's wireless heart failure sensor cleared for NHS use
A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.
Debates
News
Press Releases
Editor's Picks
Editor's Picks
